MQS Management’s AtriCure ATRC Stock Holding History

MQS Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,698	Closed	-$275K	–	447
2023 Q4	$275K	Buy	+7,698	New	+$286K	0.15%	292

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MQS Management's ATRC Position: Q1 2024 in Review

MQS Management sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 7,698 shares — an estimated $275K sold.

MQS Management first reported a position in ATRC in Q4 2023 and held it in 1 quarter. The position peaked at $275K in Q4 2023. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.

MQS Management reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
MQS Management sold 7,698 AtriCure shares in Q1 2024, an estimated $275K.
MQS Management first reported a position in AtriCure in Q4 2023 and held it in 1 quarter.
MQS Management's AtriCure position peaked at $275K in Q4 2023.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.

Based on MQS Management's 13F filing for Q1 2024, filed 14 May 2024.